TipRanks
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market
GTHP
Guided Therapeutics
RESEARCH TOOLSreports

Guided Therapeutics (GTHP) Ratios

29 Followers

Guided Therapeutics Ratios

GTHP's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, GTHP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.09 0.09 0.19 0.29 0.62
Quick Ratio
 <0.01 0.02 0.09 0.16 0.50
Cash Ratio
 <0.01 <0.01 0.06 0.12 0.48
Solvency Ratio
 -0.52 -0.42 -0.37 -0.62 -0.68
Operating Cash Flow Ratio
 -0.24 -0.16 -0.18 -0.36 -0.30
Short-Term Operating Cash Flow Coverage
 -0.78 -0.49 -0.58 -1.34 -1.83
Net Current Asset Value
$ -6.43M$ -6.72M$ -5.07M$ -4.08M$ -3.25M
Leverage Ratios
Debt-to-Assets Ratio
 2.33 2.22 1.57 1.23 0.67
Debt-to-Equity Ratio
 -0.48 -0.49 -0.44 -0.54 -0.78
Debt-to-Capital Ratio
 -0.94 -0.96 -0.79 -1.18 -3.65
Long-Term Debt-to-Capital Ratio
 -0.03 >-0.01 -0.01 -0.16 -0.64
Financial Leverage Ratio
 -0.21 -0.22 -0.28 -0.44 -1.17
Debt Service Coverage Ratio
 -1.27 -0.88 -0.84 -1.98 -2.65
Interest Coverage Ratio
 -3.65 -3.84 -5.53 -12.44 -5.73
Debt to Market Cap
 0.11 0.05 0.23 0.23 0.20
Interest Debt Per Share
 0.04 0.05 0.04 0.05 0.09
Net Debt to EBITDA
 -1.09 -1.16 -0.91 -0.47 0.01
Profitability Margins
Gross Profit Margin
64.00%74.45%28.57%36.73%-523.08%
EBIT Margin
-406.77%-336.25%-29085.71%-3276.53%-28915.38%
EBITDA Margin
-390.92%-322.29%-27728.57%-3189.80%-28361.54%
Operating Profit Margin
-337.23%-309.26%-30114.29%-3527.55%-25638.46%
Pretax Profit Margin
-471.23%-416.69%-34528.57%-3560.20%-33392.31%
Net Profit Margin
-573.08%-416.69%-34528.57%-3560.20%-33392.31%
Continuous Operations Profit Margin
-573.08%-416.69%-34528.57%-3560.20%-33392.31%
Net Income Per EBT
121.61%100.00%100.00%100.00%100.00%
EBT Per EBIT
139.74%134.74%114.66%100.93%130.24%
Return on Assets (ROA)
-311.72%-241.39%-175.40%-209.05%-128.97%
Return on Equity (ROE)
65.96%53.21%49.44%91.67%150.57%
Return on Capital Employed (ROCE)
44.07%44.65%44.13%110.10%221.76%
Return on Invested Capital (ROIC)
73.63%77.34%77.22%197.77%541.95%
Return on Tangible Assets
-311.72%-241.39%-175.40%-209.05%-128.97%
Earnings Yield
-20.30%-7.55%-28.10%-44.45%-44.52%
Efficiency Ratios
Receivables Turnover
 162.50 191.75 2.33 14.00 2.17
Payables Turnover
 0.10 0.08 <0.01 0.03 0.04
Inventory Turnover
 0.47 0.44 <0.01 0.10 0.15
Fixed Asset Turnover
 1.00 1.09 0.04 0.38 0.04
Asset Turnover
 0.54 0.58 <0.01 0.06 <0.01
Working Capital Turnover Ratio
 -0.12 -0.14 >-0.01 -0.04 >-0.01
Cash Conversion Cycle
 -2.93K -3.72K -109.12K -8.16K -7.39K
Days of Sales Outstanding
 2.25 1.90 156.43 26.07 168.46
Days of Inventory Outstanding
 779.91 834.29 46.21K 3.72K 2.47K
Days of Payables Outstanding
 3.71K 4.56K 155.49K 11.91K 10.03K
Operating Cycle
 782.16 836.19 46.37K 3.75K 2.64K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.02 -0.01 -0.02 -0.03 -0.05
Free Cash Flow Per Share
 -0.02 -0.01 -0.02 -0.03 -0.05
CapEx Per Share
 <0.01 <0.01 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 -17.90 -7.03 -6.43 0.00 -47.68
Capital Expenditure Coverage Ratio
 -752.00 -534.00 0.00 0.00 -47.68
Operating Cash Flow Coverage Ratio
 -0.54 -0.36 -0.52 -0.85 -0.65
Operating Cash Flow to Sales Ratio
 -2.31 -1.39 -159.86 -17.82 -113.69
Free Cash Flow Yield
-8.21%-2.53%-13.01%-22.25%-15.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.75 -12.65 -3.32 -2.25 -2.25
Price-to-Sales (P/S) Ratio
 28.23 55.21 1.23K 80.09 750.12
Price-to-Book (P/B) Ratio
 -3.18 -7.05 -1.76 -2.06 -3.38
Price-to-Free Cash Flow (P/FCF) Ratio
 -12.19 -39.57 -7.69 -4.50 -6.46
Price-to-Operating Cash Flow Ratio
 -12.20 -39.65 -7.69 -4.50 -6.60
Price-to-Earnings Growth (PEG) Ratio
 -2.00 2.29 0.09 0.04 0.13
Price-to-Fair Value
 -3.18 -7.05 -1.76 -2.06 -3.38
Enterprise Value Multiple
 -8.31 -18.29 -5.34 -2.98 -2.63
Enterprise Value
 21.13M 45.22M 10.37M 9.32M 9.70M
EV to EBITDA
 -8.31 -18.29 -5.34 -2.98 -2.63
EV to Sales
 32.50 58.96 1.48K 95.06 746.27
EV to Free Cash Flow
 -14.03 -42.26 -9.27 -5.34 -6.43
EV to Operating Cash Flow
 -14.05 -42.34 -9.27 -5.34 -6.56
Tangible Book Value Per Share
 -0.06 -0.08 -0.09 -0.07 -0.09
Shareholders’ Equity Per Share
 -0.06 -0.08 -0.09 -0.07 -0.09
Tax and Other Ratios
Effective Tax Rate
 -0.22 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.04 -0.04 -0.04 -0.07 -0.13
Tax Burden
 1.22 1.00 1.00 1.00 1.00
Interest Burden
 1.16 1.24 1.19 1.09 1.15
Research & Development to Revenue
 0.52 0.61 75.14 2.33 5.92
SG&A to Revenue
 3.61 3.23 226.29 30.58 231.31
Stock-Based Compensation to Revenue
 0.19 0.49 17.14 18.43 106.23
Income Quality
 0.49 0.33 0.46 0.50 0.34
Currency in USD